Dose Effect Evaluation and Therapeutic Window of the Neuro-EPO Nasal Application for the Treatment of the Focal Ischemia Model in the Mongolian Gerbil

Figure 2

Clinical signs of stroke at 24 h of permanent occlusion of the right common carotid in the Mongolian gerbil, evaluating different doses of the intranasal formulation of Neuro-EPO. Numbers indicate significant difference between bars in the U test of Mann and Whitney in respect with vehicle. (𝑛=35 per group).